SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Top Story - Ranbaxy Laboratories new malaria drug proves effective and safe in mid-stage trial

26 Aug 2010 Evaluate

An experimental malaria drug developed by Ranbaxy Laboratories Ltd. was effective and safe in a mid-stage clinical trial, according to a study that suggests the treatment may offer an alternative to current medicines. Among 230 people with the deadliest form of malaria in Thailand, India and Tanzania, Ranbaxy’s arterolane cleared the disease in as many as 72 percent of patients within 28 days.

Malaria strikes about 250 million people each year and kills more than 880,000, mostly children under 5 in Africa, according to the World Health Organization. It’s the world’s third-deadliest infectious disease, with only AIDS, which results in about 2 million deaths each year, and tuberculosis, which kills 1.6 million people annually, according to WHO.

A study published in the New England Journal of Medicine last year showed drugs derived from artemisinin took almost twice as long to clear the parasites that cause the disease in patients in western Cambodia as in patients in northwestern Thailand. Ranbaxy is now studying arterolane in combination with an older drug, piperaquine, in a late-stage patient study in India, Bangladesh and Thailand.

crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×